【结 构 式】 |
【分子编号】55991 【品名】4'-{2-[(3-fluorobenzyl)amino]ethoxy}[1,1'-biphenyl]-4-ol 【CA登记号】 |
【 分 子 式 】C21H20FNO2 【 分 子 量 】337.3937432 【元素组成】C 74.76% H 5.97% F 5.63% N 4.15% O 9.48% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(VI)The alkylation of 4,4'-dihydroxybiphenyl (I) with ethyl bromoacetate (II) in the presence of sodium methoxide afforded the (biphenylyloxy)acetate (III). Heating of ester (III) with m-fluorobenzylamine (IV) at 85 C produced amide (V), which was subsequently reduced to amine (VI) by means of borane, generated in situ from NaBH4 and BF3. Finally, condensation of the secondary amine (VI) with methyl isocyanate gave rise to the title urea derivative.
【1】 Fex, T.; Asp, B.; Stamvik, A.; Carlsson, J.-I.; Billstrom, A. (Pharmacia AB); Novel antitumour cpds. with antimitotic activity. WO 9529155 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 55986 | 4,4'-Biphenol; 4,4'-Dihydroxybiphenyl; 4,4'-Dihydroxydiphenyl; 4,4'-Diphenol | 92-88-6 | C12H10O2 | 详情 | 详情 |
(II) | 16640 | Ethyl 2-bromoacetate; Ethyl bromoacetate | 105-36-2 | C4H7BrO2 | 详情 | 详情 |
(III) | 55987 | ethyl 2-[(4'-hydroxy[1,1'-biphenyl]-4-yl)oxy]acetate | C16H16O4 | 详情 | 详情 | |
(IV) | 48834 | 3-Fluorobenzylamine | 100-82-3 | C7H8FN | 详情 | 详情 |
(V) | 55990 | N-(3-fluorobenzyl)-2-[(4'-hydroxy[1,1'-biphenyl]-4-yl)oxy]acetamide | C21H18FNO3 | 详情 | 详情 | |
(VI) | 55991 | 4'-{2-[(3-fluorobenzyl)amino]ethoxy}[1,1'-biphenyl]-4-ol | C21H20FNO2 | 详情 | 详情 |
Extended Information